Author:
Simon Jason S.,Karnoub Maha C.,Devlin David J.,Arreaza Maria G.,Qiu Ping,Monks Stephanie A.,Severino Michael E.,Deutsch Paul,Palmisano Joanne,Sachs Alan B.,Bayne Marvin L.,Plump Andrew S.,Schadt Eric E.
Reference26 articles.
1. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption;Altmann;Science,2004
2. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1);Garcia-Calvo;Proc. Natl. Acad. Sci. USA,2005
3. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia;Dujovne;Am. J. Cardiol.,2002
4. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies;Knopp;Int. J. Clin. Pract.,2003
5. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia;Knopp;Eur. Heart J.,2003
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献